Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Northvale, NJ
SEC filing record 1 source field available
Fiscal year end
31 March
ELITE PHARMACEUTICALS INC /NV/ has filed 1,215 SEC EDGAR filings since 30 Jan 1998

SEC filing history

Showing 476-500 of 753 matching filings.

Per page
25
Current page
20
4

PRIMARY DOCUMENT

Filing date
18 Sep 2013
Reporting date
10 Sep 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Sep 2013
Reporting date
10 Sep 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-15697

8-K

Filing date
18 Sep 2013
Reporting date
17 Sep 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-15697

CT ORDER filing

Filing date
16 Sep 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-15697

8-K

Filing date
13 Sep 2013
Reporting date
10 Sep 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-15697

FORM 8-K

Filing date
23 Aug 2013
Reporting date
19 Aug 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
21 Aug 2013
Reporting date
01 Aug 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-188139

424B3

Filing date
14 Aug 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-15697

FORM 8-K

Filing date
06 Aug 2013
Reporting date
02 Aug 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-188139

424B3

Filing date
05 Aug 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-15697

8-K

Filing date
05 Aug 2013
Reporting date
01 Aug 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-188139

EFFECT filing

Filing date
27 Jun 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-188139

FORM 424B3

Filing date
27 Jun 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-15697

ANNUAL REPORT

Filing date
21 Jun 2013
Reporting date
31 Mar 2013
Next action
Verify source filing
8-K File 001-15697

8-K

Filing date
21 May 2013
Reporting date
15 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 May 2013
Reporting date
09 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 May 2013
Reporting date
09 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 May 2013
Reporting date
09 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 May 2013
Reporting date
09 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 May 2013
Reporting date
09 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-188139

424B3

Filing date
10 May 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-188139

EFFECT filing

Filing date
09 May 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
30 Apr 2013
Reporting date
26 Apr 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .